Matthew R. Plooster is Director at KEMPHARM, INC (KMPH). They have made 2 open-market trades across 2 companies since 2022, most recently 2023-03-09.
CIK 0001638364
2 open-market purchases totalling $71K since 2022, never a sale. Too few scored purchases to measure a record yet.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.